Septic Shock: Clinical Trials

71 trials for Septic Shock, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

33 completed, 13 unknown, 10 terminated, 9 recruiting. 71 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 471Completed 33, Unknown 13, Terminated 10, Recruiting 9, Not yet recruiting 4, Active not recruiting 1, Withdrawn 1

Follow Septic Shock: new trials by email Literature Review of Septic Shock trials Research Report on Septic Shock

Trials (filtered) newest first · largest first

All 71 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Mechanistic Assessment of Norepinephrine Therapy vs. Angiotensin-II in Septic Shock
Angiotensin II, Norepinephrine - Septic Shock
Phase 4Not yet recruitingWake Forest University Health Sciences782026-11-012026-09-24
Hydrocortisone and Fludrocortisone for the Treatment of Septic Shock
Hydrocortisone plus Fludrocortisone, Standard care - Septic Shock
Phase 4RecruitingNorthern Jiangsu People's Hospital3362026-03-022026-03-04
Early Dexmedetomidine and Sympathetic Regulation in Sepsis
Dexmedetomidine (DEX), Placebo - Sepsis, Septic Shock
Phase 4Not yet recruitingSichuan Academy of Medical Sciences1682026-03-012026-03-13
Thymosin Alpha 1 and IgM Levels in Sepsis
Thymalfasin - Sepsis, Septic Shock
Phase 4Active not recruitingSoutheast University, China362026-02-202026-11-06
Continuous Infusion Versus Intermittent Bolus Hydrocortisone in Septic Shock
Hydrocortisone Continuous Infusion, Hydrocortisone Intermittent Bolus - Septic Shock
Phase 4CompletedBenha University1102026-01-012026-07-10
Randomized Control Study in REsuscitation of SEpsis Trial
Pharmaceutical fresh frozen plasma, Normal Saline, Ringer lactate (RL) - Septic Shock, Pediatric Critical Illness
Phase 4Not yet recruitingFundación Cardioinfantil Instituto de Cardiología1502025-07-012025-06-25
Empirical Meropenem Versus Piperacillin/Tazobactam for Adult Patients With Sepsis
Meropenem, Piperacillin/Tazobactam - Sepsis, Septic Shock
Phase 4RecruitingScandinavian Critical Care Trials Group58002025-06-262025-07-03
Early Versus Late Adjunctive Vasopressin in Septic Shock
vasopressin - early initiation, vasopressin - standard initiation - Sepsis, Septic Shock
Phase 4RecruitingThe Cleveland Clinic3002025-04-292026-08-31
Shenfu Injection Modulates Carotid Elasticity in Septic Shock
Shenfu Injection - Septic Shock, Vascular Dysfunction
Phase 4Not yet recruitingFirst Affiliated Hospital of Wannan Medical College482025-04-152025-04-08
Early Angiotensin II in the Emergency Department
Angiotensin II Infusion - Septic Shock
Phase 4RecruitingBrett A Faine202025-04-012026-09-02
Oral Bedtime Melatonin in Critically Ill Patients
Oral Bedtime Melatonin, Placebo suspension or capsule - Septic Shock, Stroke Hemorrhagic
Phase 4UnknownHospital San Carlos, Madrid1602025-02-012024-03-01
Beta-Lactam Antibiotics InitiaL ExpoSure OptimisEd in CriticallY Ill Patients with SEpsis
Double dosing of beta-lactam antibiotic - Sepsis - to Reduce Mortality in the Intensive Care Unit, Sepsis
Phase 4RecruitingErasmus Medical Center9802025-01-032025-01-09
Use of Epoetin Alfa and Iron Derisomaltose in Treatment of Anemia in Patients With Sepsis or Septic Shock: a Randomized Controlled Trial
Iron, EPO, 0.9 % NaCl - Anemia, Sepsis
Phase 4RecruitingPiotr Czempik2002024-11-102024-12-27
The Effect of Dexmedetomidine on the Renal Functions in Septic Critically Ill Patients
Dexmedetomidine, Propofol - Sepsis, Septic Shock
Phase 4RecruitingCairo University1282024-10-012024-10-09
The Preventive Effect of Shenfu Injection on Myocardial Dysfunction in Sepsis
Shenfu Injection - Septic Cardiomyopathy, Septic Shock
Phase 4RecruitingFirst Affiliated Hospital of Wannan Medical College4402024-10-012025-03-27
Renal Outcomes in the Early Use of Vasopressin in the Treatment of Septic Shock
vasopressin infusion when the norepinephrine dosage is equal to or greater than 0.25 mcg/kg/min, vasopressin infusion when the norepinephrine dosage is equal to or greater than 0.5 mcg/kg/min - Septic Shock, Renal Function Replacement
Phase 4UnknownAzienda Usl di Bologna2642024-05-152024-06-24
Vasopressin for Septic Shock Pragmatic Trial
Vasopressin, Recommendation to use a lower initiation threshold for vasopressin, Recommendation to use a higher initiation threshold for vasopressin - Septic Shock
Phase 4CompletedIntermountain Health Care, Inc.39592024-02-012026-08-03
Hemodynamic Response to Angiotensin-II When Used as the Second Vasopressor Agent for Septic Shock
Angiotensin II and hydrocortisone sodium succinate - Septic Shock, Shock
Phase 4UnknownKingman Regional Medical Center502023-12-042024-05-23
The Construction and Application of Therapeutic System of Intelligent Decision-Oriented Hemodynamic Organized Therapy for Shock Patients
norepinephrine+vasopressin, Norepinephrine - Septic Shock
Phase 4UnknownPeking Union Medical College Hospital602023-05-012023-06-02
Role of Ulinastatin in Preventing Severe Sepsis and Consequent Morbidities and Mortality
Ulinastatin - Severe Sepsis, Septic Shock
Phase 4UnknownJinnah Postgraduate Medical Centre1752023-05-012023-06-08

Showing 20 of 71. Sign in to see all of them.

Narrower conditions

Shock, Septic (71)  ·  Sepsis (34)  ·  Diabetes Insipidus (6)  ·  Acute Kidney Injury (4)  ·  Shock (4)  ·  Critical Illness (2)  ·  Systemic Inflammatory Response Syndrome (2)  ·  Anemia (1)  ·  Arrhythmias, Cardiac (1)  ·  Cardiomyopathies (1)  ·  Edema (1)  ·  Emergencies (1)  ·  Fibrosis (1)  ·  Gram-Negative Bacterial Infections (1)  ·  Heart Arrest (1)

Broader conditions

Infections (71)  ·  Inflammation (71)  ·  Pathologic Processes (71)  ·  Pathological Conditions, Signs and Symptoms (71)  ·  Systemic Inflammatory Response Syndrome (69)  ·  Shock (67)  ·  Sepsis (37)  ·  Female Urogenital Diseases (11)  ·  Female Urogenital Diseases and Pregnancy Complications (11)  ·  Male Urogenital Diseases (11)  ·  Urogenital Diseases (11)  ·  Urologic Diseases (11)  ·  Kidney Diseases (10)  ·  Cardiovascular Diseases (6)  ·  Endocrine System Diseases (6)

Interventions

Norepinephrine (7)  ·  Hydrocortisone (6)  ·  Sodium Chloride (6)  ·  Angiotensin II (5)  ·  Dexmedetomidine (5)  ·  Saline Solution (5)  ·  Vasopressins (4)  ·  Ascorbic Acid (3)  ·  Crystalloid Solutions (3)  ·  Giapreza (3)  ·  Midazolam (3)  ·  Adrenal Cortex Hormones (2)  ·  Albumins (2)  ·  Fentanyl (2)  ·  Fludrocortisone (2)

Sponsors

Southeast University, China (6)  ·  Cairo University (3)  ·  Ain Shams University (2)  ·  Asan Medical Center (2)  ·  First Affiliated Hospital of Wannan Medical College (2)  ·  Peking Union Medical College Hospital (2)  ·  The Cleveland Clinic (2)  ·  University of New Mexico (2)  ·  Alexander Flannery (1)  ·  Anders Perner (1)  ·  Anders Perner, MD, PhD (1)  ·  Assistance Publique Hopitaux De Marseille (1)  ·  Association Niçoise de Réanimation Médicale (1)  ·  Association Pour La Promotion A Tours De La Reanimation Medicale (1)  ·  Association pour le Développement de la Recherche et de l'Enseignement en Médecine d'Urgence (1)

Countries

United States (14)  ·  China (10)  ·  Egypt (7)  ·  France (7)  ·  Denmark (5)  ·  Brazil (4)  ·  Italy (3)  ·  Sweden (3)  ·  Australia (2)  ·  Czechia (2)  ·  South Korea (2)  ·  Switzerland (2)  ·  United Kingdom (2)  ·  Austria (1)  ·  Belgium (1)

Top investigators

Joao P Teixeira, MD (2)  ·  Nathan D Nielsen, MD MSc (2)  ·  Ahmed Mukhtar (1)  ·  Alessandro Pontes-Arruda, MD, PhD (1)  ·  Alexander H Flannery, Pharm.D. (1)  ·  Amany M Mohamed, Ph.D (1)  ·  Anders Perner, MD PhD (1)  ·  Ashish Khanna, MD (1)  ·  Balasubramanian Venkatesh (1)  ·  Bethany A Kalich (1)  ·  Bin Du, MD (1)  ·  Cassio Mallmann, MD (1)

Results publications

PMID 23963131, PMID 30394918, PMID 34605781, PMID 11529214, PMID 11588440, PMID 12500513, PMID 12519925, PMID 15187514, PMID 15343008, PMID 16134766, PMID 16879732, PMID 18305265, PMID 18698227, PMID 19068113, PMID 19531784, PMID 19703817, PMID 19926252, PMID 20109575, PMID 20725823, PMID 21545483, PMID 22477787, PMID 22518026, PMID 23796235, PMID 24151551, PMID 24370612, PMID 24794878, PMID 25313879, PMID 25457118, PMID 25887027, PMID 26903338, PMID 27111533, PMID 27398737, PMID 27480413, PMID 27483065, PMID 27686349, PMID 28409297, PMID 28618919, PMID 28659186, PMID 28750598, PMID 28785470, PMID 28866112, PMID 28903154, PMID 28973220, PMID 29290746, PMID 29319721, PMID 29328496, PMID 29347874, PMID 29467017, PMID 29784057, PMID 29859008

NIH funding

2014 (1), 2016 (1), 2017 (1), 2023 (1), R01HL177834 (1), UL1RR024975-01 (1), UL1TR000445-06 (1), UL1TR001449 (1)